Abstract:Background Adenine base editors (ABEs) are promising therapeutic gene editing tools that can efficiently convert targeted A•T to G•C base pairs in the genome. However, the large size of commonly used ABEs based on SpCas9 hinders its delivery in vivo using certain vectors such as adeno-associated virus (AAV) during preclinical applications. Despite a number of approaches having previously been attempted to overcome that challenge, including split Cas9-derived and numerous domain-deleted versions of editors, whether base editor (BE) and prime editor (PE) systems can also allow deletion of those domains remains to be proven. In this study, we present a new small ABE (sABE) with significantly reduced size. Results We discovered that ABE8e can tolerate large single deletions in the REC2 (Δ174-296) and HNH (Δ786-855) domains of SpCas9, and these deletions can be stacked together to create a new sABE. The sABE showed higher precision than the original ABE8e, with proximally shifted protospacer adjacent motif (PAM) editing windows (A3- A15), and comparable editing efficiencies to 8e-SaCas9-KKH. The sABE system efficiently generated A-G mutations at disease-relevant loci (T1214C in GAA and A494G in MFN2 ) in HEK293T cells and several canonical Pcsk9 splice sites in N2a cells. Moreover, the sABE enabled in vivo delivery in a single adeno-associated virus (AAV) vector with slight efficiency. Furthermore, we also successfully edited the genome of mouse embryos by microinjecting mRNA and sgRNA of sABE system into zygotes. Conclusions We have developed a substantially smaller sABE system that expands the targeting scope and offers higher precision of genome editing. Our findings suggest that the sABE system holds great therapeutic potential in preclinical applications.

Accelerated discovery and miniaturization of novel single-stranded cytidine deaminases

Efficient DNA base editing via an optimized DYW-like deaminase

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

Increasing the Efficiency and Targeting Range of Cytidine Base Editors Through Fusion of a Single-Stranded DNA-binding Protein Domain

Engineering APOBEC3A deaminase for highly accurate and efficient base editing

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation

TadA reprogramming to generate potent miniature base editors with high precision

Direct delivery of stabilized Cas-embedded base editors achieves efficient and accurate editing of clinically relevant targets

A New Compact Adenine Base Editor Generated Through Deletion of HNH and REC2 Domain of SpCas9

Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e

Engineering of cytosine base editors with DNA damage minimization and editing scope diversification

Structure-guided discovery of highly efficient cytidine deaminases with sequence-context independence

Efficient in Vivo Base Editing Via Single Adeno-Associated Viruses with Size-Optimized Genomes Encoding Compact Adenine Base Editors

Compact RNA editors with natural miniature Cas13j nucleases

Engineering precise adenine base editor with infinitesimal rates of bystander mutations and off-target editing

Efficient generation of site-specific point mutations in cell lines by hyper active CBEs (hyCBEs)

Adenine Base Editing in vivo with a Single Adeno-Associated Virus Vector

ACBE, a new base editor for simultaneous C-to-T and A-to-G substitutions in mammalian systems

Expanding C–T base editing toolkit with diversified cytidine deaminases

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences